- $5.10bn
- $4.61bn
- $980.60m
Novanta beats Q2 revenue estimates on organic growth, raises 2026 guidance
Novanta Inc expected to post earnings of 83 cents a share - Earnings Preview
Brief: Novanta Completes Acquisition Of Riverpoint Medical
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM
NASDAQ RESUMED AT 09:45 AM
NASDAQ RESUMED AT 09:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
NASDAQ RESUMED AT 09:38 AM
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:36 AM
NASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
Brief: Novanta Inc. Announces $300 Million Private Placement
Brief: Novanta Inc. Announces Acquisition Of Riverpoint Medical
Brief: Novanta Inc -Co And Units Enter Second Amendment To Credit Agreement On May 15, 2026 - SEC Filing
Brief: Novanta Announces Financial Results For The First Quarter 2026